Dr. Giuseppe Saglio CML Chronic Myeloid Leukemia
''Dr. Giuseppe Saglio is Professor of Internal Medicine and Haematology at the University of Turin. He is Director of the Department of Molecular Medicine and Targeted Therapy and responsible for the Division of Internal Medicine and Haematology at San Luigi Hospital (University of Turin) .''
Extract from iCMLf
VIDEOS in English
Is it possible to achieve TFR with low-dose TKI therapy?
October 25, 2022, VJHemOnc – Video Journal of Hematological Oncology
The Changing CML Treatment Paradigm
February 2, 2015, Patient Power
Dr Giuseppe Saglio Compares Efficacy, Safety of Nilotinib with Imatinib for CML Patients
December 8, 2014, AJMCtv
Dr. Giuseppe Saglio at BTG2011
August 7, 2011,TheMedalGroup
Is it possible to achieve TFR with low-dose TKI therapy?
October 25, 2022, VJHemOnc – Video Journal of Hematological Oncology
The Changing CML Treatment Paradigm
February 2, 2015, Patient Power
Dr Giuseppe Saglio Compares Efficacy, Safety of Nilotinib with Imatinib for CML Patients
December 8, 2014, AJMCtv
Dr. Giuseppe Saglio at BTG2011
August 7, 2011,TheMedalGroup
VIDEOS in Italian
Leucemia mieloide cronica: conosciamola da vicino con l'aiuto di un grande esperto
January 18, 2015, PharmaStarTV
Giuseppe Saglio - Nuove prospettive terapeutiche per la LMC
May 24, 2012, Mattioli editore
Giuseppe Saglio - Imatinib e terapia di seconda linea
February 28, 2012, Mattioli editore
Giuseppe Saglio - leucemia mieloide cronica
October 26, 2011, Mattioli editore
ARTICLES
Prospects for achieving treatment‐free remission in chronic myeloid leukaemia
February 14, 2020, British Journal of Haematology
Prospects for achieving treatment‐free remission in chronic myeloid leukaemia
February 14, 2020, British Journal of Haematology
